Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice

Genetics in Medicine

Volumn 14, Issue 10, 2012, Pages 860-867

  Kolor, Katherine ^a   Duquette, Debra ^b   Zlot, Amy ^c   Foland, Joan ^d   Anderson, Beth ^b   Giles, Rebecca ^e   Wrathall, Jennifer ^e   Khoury, Muin J ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

^d CDC   (United States)

^e UTAH DEPARTMENT OF HEALTH   (United States)

Author keywords

awareness and use; direct to consumer; personal genomic tests; population based; practice implications

Indexed keywords

ARTICLE; AWARENESS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CLINICAL PRACTICE; COMPARATIVE STUDY; CONSUMER; EDUCATIONAL STATUS; GENETIC SCREENING; GENOMICS; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; POPULATION RESEARCH; PUBLIC HEALTH SERVICE;

EID: 84864609933     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.67     Document Type: Article

References (37)

1. Genomics and Public Policy Center. Survey of Direct-to-Consumer Testing Statutes and Regulations. 2007. http://www.dnapolicy.org/resources/ DTCStateLawChart.pdf. Accessed 21 March 2012.
2. 23andme. Shipping. https://www.23andme.com/store/shipping/. Accessed 21 March 2012.
3. deCODEme. Service Agreement. https://www.decodeme.com/serviceagreement. Accessed 2 April 2012.
4. McGuire A, Burke W. An unwelcome side effect of direct-to-consumer personal genome testing: Raiding the medical commons. JAMA 2008;300:2669-2671.
5. Hogarth S, Javitt G, Melzer D. The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet 2008;9:161-182.
6. Caulfield T, McGuire AL. Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annu Rev Med 2012;63:23-33.
7. Spencer DH, Lockwood C, Topol E, et al. Direct-to-consumer genetic testing: reliable or risky? Clin Chem 2011;57:1641-1644.
8. Khoury MJ, McBride CM, Schully SD, et al.; Centers for Disease Control and Prevention. The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009;11:559-567.
9. U.S. House of Representatives Committee on Energy and Commerce. Hearing on "Direct-To-Consumer Genetic Testing and the Consequences to the Public Health." 2010. http://democrats.energycommerce.house. gov/index.php?q= hearing/hearing-on-direct-to-consumer-genetictesting-and-the-consequences-to- the-public-health. Accessed 8 September 2011.
10. U.S. Government Accountability Office. Direct-To-Consumer Genetic Tests: Misleading Test Results Are Further Complicated by Deceptive Marketing and Other Questionable Practices. 2010. http://www.gao.gov/new.items/d10847t.pdf. Accessed 8 September 2011.
11. Ortiz AP, Lez M, Flores LT, et al. Awareness of direct-to-consumer genetic tests and use of genetic tests among Puerto Rican adults, 2009. Prev Chronic Dis 2011;8:A110.
12. Kolor K, Liu T, St Pierre J, Khoury MJ. Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med 2009;11:595.
13. Langford AT, Resnicow K, Roberts JS, Zikmund-Fisher BJ. "Racial and Ethnic Differences in Direct-to-Consumer Genetic Tests Awareness in HINTS 2007: Sociodemographic and Numeracy Correlates". J Genet Couns 2012;21: 440-447.
14. Goddard KA, Duquette D, Zlot A, et al. Public awareness and use of directto-consumer genetic tests: results from 3 state population-based surveys 2006. Am J Public Health 2009;99:442-445.
15. Centers for Disease Control and Prevention. 2009 BRFSS Summary Data Quality Report, Version #1, Table 11: BRFSS outcome rates by state. 2011. ftp://ftp.cdc.gov/pub/Data/Brfss/2009-Summary-Data-Quality-Report.pdf. Accessed 17 May 2011.
16. McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med 2009;11: 582-587.
17. Bloss CS, Ornowski L, Silver E, et al. Consumer perceptions of directto-consumer personalized genomic risk assessments. Genet Med 2010;12:556-566.
18. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG. Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth 2009;9:3-10.
19. Kaufman DJ, Bollinger JM, Dvoskin RL, Scott JA. Risky Business: Risk Perception and the Use of Medical Services among Customers of DTC Personal Genetic Testing. J Genet Couns 2012;21:413-422.
20. Leighton JW, Valverde K, Bernhardt BA. The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics 2012;15:11-21.
21. Cherkas LF, Harris JM, Levinson E, Spector TD, Prainsack B. A survey of UK public interest in internet-based personal genome testing. PLoS ONE 2010;5:e13473.
22. Goldsmith L, Jackson L, O'Connor A, Skirton H. Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. Eur J Hum Genet; e-pub ahead of print February 2012.
23. Wright CF, Gregory-Jones S. Size of the direct-to-consumer genomic testing market. Genet Med 2010;12:594.
24. Pollack A. Consumers slow to embrace the age of genomics. NY Times (Print). 2010. http://www.nytimes.com/2010/03/20/business/20consumergene. html?-r=2&fta=y. Accessed 2 April 2012.
25. Sweeny K, Legg AM. Predictors of interest in direct-to-consumer genetic testing. Psychol Health 2011;26:1259-1272.
26. Rahm AK, Feigelson HS, Wagner N, et al. Perception of Direct-To-Consumer Genetic Testing and Direct-To-Consumer Advertising of Genetic Tests among Members of a Large Managed Care Organization. J Genet Couns 2012;21:448-461.
27. Liu Y, Pearson YE. Direct to consumer marketing of predictive medical genetic tests: assessment of current practices and policy recommendations. J Publ Pol Market 2008;27:131-148.
28. Hensley Alford S, McBride CM, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Participation in genetic testing research varies by social group. Public Health Genomics 2011;14:85-93.
29. Lachance CR, Erby LA, Ford BM, Allen VC Jr, Kaphingst KA. Informational content, literacy demands, and usability of websites offering healthrelated genetic tests directly to consumers. Genet Med 2010;12: 304-312.
30. Burrill & Company. Personalized Medicine and Wellness Survey: Executive Summary. http://www.burrillandco.com/content/CWSurvey-61708.pdf. Accessed 1 April 2012.
31. Wilde A, Meiser B, Mitchell PB, Hadzi-Pavlovic D, Schofield PR. Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample. Psychol Med 2011;41:1605-1613.
32. Gollust SE, Gordon ES, Zayac C, et al. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics 2012;15:22-30.
33. Skirton H, Goldsmith L, Jackson L, O'Connor A. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet; e-pub ahead of print February 2012.
34. Haga SB, Carrig MM, O'Daniel JM, et al. Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J Gen Intern Med 2011;26:834-840.
35. McGuire AL, Evans BJ, Caulfield T, Burke W. Science and regulation. Regulating direct-to-consumer personal genome testing. Science 2010;330:181-182.
36. Su Y, Howard HC, Borry P. Users' motivations to purchase direct-toconsumer genome-wide testing: an exploratory study of personal stories. J Community Genet 2011;2:135-146.
37. Khoury MJ, Bowen MS, Burke W, et al. Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med 2011;40:486-493.